These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12503407)

  • 21. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant
    Abdel Halim RM; Saber SM; Fahim NAE
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence and Characterization of Integrons in Multidrug Resistant Acinetobacter baumannii in Eastern China: A Multiple-Hospital Study.
    Chen J; Li H; Yang J; Zhan R; Chen A; Yan Y
    Int J Environ Res Public Health; 2015 Aug; 12(8):10093-105. PubMed ID: 26308028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro effect of ampicillin/sulbactam on Acinetobacter species.
    Hostacká A
    Microbios; 2001; 106 Suppl 2():97-104. PubMed ID: 11548205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and antimicrobial susceptibility of Acinetobacter from raw bulk tank milk in Korea.
    Gurung M; Nam HM; Tamang MD; Chae MH; Jang GC; Jung SC; Lim SK
    J Dairy Sci; 2013 Apr; 96(4):1997-2002. PubMed ID: 23462164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period.
    Ruiz J; Núñez ML; Pérez J; Simarro E; Martínez-Campos L; Gómez J
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):292-5. PubMed ID: 10385020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Suh B; Shapiro T; Jones R; Satishchandran V; Truant AL
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):111-4. PubMed ID: 7628190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
    Kuah BG; Kumarasinghe G; Doran J; Chang HR
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2502-3. PubMed ID: 7840598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of a microsphere-based array for rapid identification of Acinetobacter spp. with distinct antimicrobial susceptibilities.
    Lin YC; Sheng WH; Chang SC; Wang JT; Chen YC; Wu RJ; Hsia KC; Li SY
    J Clin Microbiol; 2008 Feb; 46(2):612-7. PubMed ID: 18039798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.
    Ko WC; Lee NY; Su SC; Dijkshoorn L; Vaneechoutte M; Wang LR; Yan JJ; Chang TC
    J Clin Microbiol; 2008 Jun; 46(6):2052-9. PubMed ID: 18385442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activities of ampicillin, sulbactam and a combination of ampicillin and sulbactam against isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated in Chile between 1990 and 1998.
    Bello H; Domínguez M; González G; Zemelman R; Mella S; Young HK; Amyes SG
    J Antimicrob Chemother; 2000 May; 45(5):712-3. PubMed ID: 10797101
    [No Abstract]   [Full Text] [Related]  

  • 32. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides.
    Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E
    J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    McLeod SM; Moussa SH; Hackel MA; Miller AA
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988095
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
    J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
    Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
    Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
    Espinal P; Roca I; Vila J
    Future Microbiol; 2011 May; 6(5):495-511. PubMed ID: 21585259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.